A 10mg vial of SLU-PP-332 provides an optimized mass of the synthetic Estrogen-Related Receptor (ERR) agonist engineered strictly for in vitro assays and preclinical cellular research. Designed for mid-to-high throughput laboratory protocols, this fill size enables researchers to prepare standardized working stock solutions for receptor-binding, metabolic, and transcriptional activation assays. PX1 Research supplies high-purity research compounds backed by batch-matched COAs to ensure reproducibility across experimental series.
A 10mg vial of SLU-PP-332 provides an optimized mass of the synthetic Estrogen-Related Receptor (ERR) agonist engineered strictly for in vitro assays and preclinical cellular research. Designed for mid-to-high throughput laboratory protocols, this fill size enables researchers to prepare standardized working stock solutions for receptor-binding, metabolic, and transcriptional activation assays. PX1 Research supplies high-purity research compounds backed by batch-matched COAs to ensure reproducibility across experimental series.
The SLU-PP-332 10mg vial specification is tailored for academic, industrial, and institutional research laboratories requiring precise quantitative yields for cell culture treatments, enzymology assays, or receptor-ligand kinetics studies. Containing exactly 10 milligrams of purified lyophilizate or crystalline solid, this mass format balances operational cost with fresh stock preparation, reducing the risk of sample degradation caused by repeated freeze-thaw cycles.
Principal investigators and laboratory managers frequently select the 10mg unit size when designing multi-well plate studies, western blot series, or quantitative real-time PCR assays measuring metabolic gene networks. If PX1 Research currently presents alternative packaging variations—such as specialized oral solid formats like SLU-PP-332 Capsules 250mcg or alternative bulk vial masses—the chemical integrity, rigorous quality control, and testing protocols remain identical across our full spectrum of all peptides and research compounds.
SLU-PP-332 is a novel synthetic small molecule identified as a potent pan-agonist of the Estrogen-Related Receptor family, exhibiting high affinity for ERRα, ERRβ, and ERRγ isoforms. Unlike classical estrogen receptors (ERα and ERβ), ERRs are orphan nuclear receptors that operate independently of endogenous estrogen binding. Preclinical literature indicates that activation of ERRα by synthetic ligands initiates transcriptional cascades governing mitochondrial biogenesis, oxidative phosphorylation, and cellular fatty acid oxidation.
In vitro assays demonstrate that SLU-PP-332 recruits nuclear receptor coactivators such as PGC-1α (peroxisome proliferators-activated receptor gamma coactivator 1-alpha) to target promoter regions. Research models utilize this molecule to evaluate baseline metabolic reprogramming in skeletal muscle cell lines (such as C2C12 myotubes) and primary hepatocytes. Because ERRα regulates key enzymes involved in the TCA cycle and electron transport chain, researchers utilize SLU-PP-332 to probe cellular bioenergetics without inducing classical estrogenic signaling pathways.
Precise reconstitution math is critical when preparing stock solutions from a 10mg vial of SLU-PP-332 to guarantee accurate micro-molar concentrations during assay dosing. Depending on the target stock concentration required for serial dilution, laboratory technicians can utilize standard volume additions of sterile diluent or solvent.
When reconstituting a 10mg vial, the resulting stock concentrations based on diluent volume are as follows:
• Adding 1.0 mL diluent yields a final stock concentration of 10.0 mg/mL (10.0 µg/µL). • Adding 2.0 mL diluent yields a final stock concentration of 5.0 mg/mL (5.0 µg/µL). • Adding 3.0 mL diluent yields a final stock concentration of 3.33 mg/mL (3.33 µg/µL).
To rapidly calculate custom molarities based on the molecular weight of SLU-PP-332 (C26H23N3O3, MW: approximately 425.48 g/mol) and your specific assay volumes, researchers should reference our interactive reconstitution calculator. Utilizing standardized mathematical calculations prevents operational error and ensures consistent compound administration across multi-plate experimental layouts.
Depending on the downstream assay environment, selecting the appropriate solvent system is essential for maintaining SLU-PP-332 in full solution. While hydrophobicity parameters dictate limited solubility in pure aqueous buffers, SLU-PP-332 readily dissolves in dimethyl sulfoxide (DMSO) or ethanol for cell culture applications. For aqueous-based biochemical assays, pre-dissolving the 10mg lyophilized mass in anhydrous DMSO to create a concentrated master stock (e.g., 50 mM or 100 mM) followed by secondary dilution into culture media with ≤0.1% final DMSO vehicle concentration is standard laboratory procedure.
Aliquot planning must be performed immediately following initial solubilization. The total stock volume should be divided into single-use microcentrifuge tubes or amber glass vials to eliminate repeated freeze-thaw cycles. Subjecting dissolved compounds to multiple temperature transitions can accelerate hydrolysis or precipitation, leading to erratic concentration gradients in quantitative assays.
PX1 Research enforces strict quality control standards for every batch of research material produced. Every SLU-PP-332 fill size, including 10mg vials, undergoes comprehensive chemical verification prior to catalog release. Laboratory researchers can view and download batch-specific documentation directly via our dedicated COA lookup portal.
Analytical verification includes High-Performance Liquid Chromatography (HPLC) to confirm chemical purity thresholds exceeding 99%, ensuring the absence of unreacted synthetic intermediates or degradation byproducts. Mass Spectrometry (MS) is simultaneously performed to verify the exact molecular mass and identity of the compound. Furthermore, endotoxin testing utilizing Chromogenic Recombinant Factor C (rFC) or LAL assays guarantees that endotoxin levels remain below strict laboratory research limits (<0.01 EU/mg), eliminating confounding inflammatory variables in cell culture protocols.
Maintaining chemical stability is vital to preserving the baseline activity of SLU-PP-332 throughout the lifecycle of a research project. In its sealed, lyophilized state, the 10mg vial should be stored in a dry, dark environment at -20°C for short-to-medium term storage, or at -80°C for long-term archival storage. Under these desiccated freezer conditions, the dry compound remains stable for up to 24 months without significant degradation.
Once solubilized in high-purity DMSO, stock solutions should be aliquoted into light-resistant, inert containers and stored at -80°C. Researchers must avoid storing working solutions in standard non-frost-free freezers, as temperature fluctuations during automatic defrost cycles compromise structural stability. Working aliquots brought to room temperature should be used immediately and discarded according to institutional biosafety guidelines.
Selecting between different mass formats depends entirely on the design, duration, and scale of your preclinical protocol. A 10mg vial of SLU-PP-332 represents an optimal configuration for medium-scale exploratory studies, cell viability screens, and gene expression profiling requiring consistent daily dosing over several weeks. Smaller formats, such as 5mg vials, may be preferred for brief pilot studies or single-plate receptor binding affinity assays to minimize wasted reagent.
Conversely, researchers conducting high-throughput screening or high-density cell line treatments may benefit from setting up dedicated institutional sourcing via our wholesale portal. Comparing liquid/lyophilized stock preparation against standardized solid media applications ensures your lab selects the format that best fits your automated liquid handlers and cell culture equipment.
In preclinical metabolic research, SLU-PP-332 is frequently evaluated alongside other small-molecule modulators targeting cellular bioenergetics, mitochondrial function, and lipid metabolism. While SLU-PP-332 operates specifically as an ERR pan-agonist, researchers often benchmark its downstream transcriptional profile against complementary pathways.
For example, compounds such as 5-Amino-1MQ act as selective inhibitors of nicotinamide N-methyltransferase (NNMT) to alter cellular NAD+ levels, whereas Rev-ErbA agonists like SR9009 regulate circadian metabolic gene expression, and PPARδ agonists such as GW501516 modulate fatty acid oxidation through distinct nuclear receptor signaling mechanisms. Conducting comparative in vitro studies across these distinct target classes allows research teams to map overlapping metabolic gene cascades in skeletal muscle and adipose tissue models.
PX1 Research operates as a premier USA-based supplier of high-purity research chemicals and peptides. All products are manufactured in compliance with strict Good Manufacturing Practice (GMP) standards within state-of-the-art facilities. Testing is conducted independently by ISO 17025 accredited analytical laboratories to provide uncompromised transparency.
Orders placed through PX1 Research ship same-day (Monday through Friday) directly from our distribution hubs in California and Arizona. This dual-coast logistics framework ensures fast delivery, minimizing shipping transit times and preserving temperature-sensitive compounds. Browse our complete catalog of compounds within our core research hub to equip your laboratory with fully verified reagents.
What is the purity level of PX1 Research's SLU-PP-332 10mg?
Every lot of SLU-PP-332 10mg undergoes HPLC and MS testing at an independent ISO 17025 accredited laboratory, guaranteeing a purity rating of ≥99.0%.
How do I reconstitute a 10mg vial of SLU-PP-332 for in vitro research?
To achieve a 10 mg/mL stock solution, add 1.0 mL of high-purity solvent (such as DMSO). Adding 2.0 mL yields 5 mg/mL, and 3.0 mL yields 3.33 mg/mL. Use our online reconstitution calculator to verify specific assay concentrations.
Is SLU-PP-332 soluble in sterile bacteriostatic water?
SLU-PP-332 exhibits hydrophobic chemical properties and has limited solubility in pure water. It is recommended to dissolve the compound first in DMSO or ethanol before making working dilutions into culture media.
Where can I obtain the batch-specific COA for my SLU-PP-332 shipment?
Batch-matched Certificates of Analysis containing full HPLC chromatograms and mass spectra are available on our COA page by entering your product lot number.
What endotoxin standards are applied to SLU-PP-332 vials?
All PX1 Research compounds are tested for bacterial endotoxins and must meet strict research thresholds (<0.01 EU/mg) to prevent cellular toxicity or non-specific inflammatory signaling in assays.
How should reconstituted SLU-PP-332 stock solutions be stored?
Reconstituted stock solutions in DMSO should be aliquoted into single-use tubes and stored at -80°C to prevent degradation and avoid repeated freeze-thaw cycles.
Are PX1 Research compounds approved for animal or human clinical use?
No. All products sold by PX1 Research, including SLU-PP-332 10mg vials, are strictly intended for laboratory in vitro and preclinical research use only. They are not for diagnostic, therapeutic, or human/veterinary consumption.
How fast will my SLU-PP-332 order ship?
Orders placed Monday through Friday before our cutoff time ship the same day from our fulfillment facilities located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.